Functional validation of genetic variants identified by next generation sequencing in malformations of cortical development

Malformations of cortical development (MCDs) result from a disruption in the process of the human brain cortex formation: currently, there are no pharmacological treatments for diffuse MCDs. Next-generation sequencing has accelerated the identification of MCDs causing genes: in some cases, functiona...

Full description

Saved in:
Bibliographic Details
Main Author: De Vita, Dalila (auth)
Format: Electronic Book Chapter
Language:English
Published: Florence Firenze University Press 2021
Series:Premio Tesi di Dottorato
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_82317
005 20220602
003 oapen
006 m o d
007 cr|mn|---annan
008 20220602s2021 xx |||||o ||| 0|eng d
020 |a 978-88-5518-344-4 
020 |a 9788855183444 
020 |a 9788855183437 
020 |a 9788855183451 
040 |a oapen  |c oapen 
024 7 |a 10.36253/978-88-5518-344-4  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MFN  |2 bicssc 
100 1 |a De Vita, Dalila  |4 auth 
245 1 0 |a Functional validation of genetic variants identified by next generation sequencing in malformations of cortical development 
260 |a Florence  |b Firenze University Press  |c 2021 
300 |a 1 electronic resource (66 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Premio Tesi di Dottorato 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Malformations of cortical development (MCDs) result from a disruption in the process of the human brain cortex formation: currently, there are no pharmacological treatments for diffuse MCDs. Next-generation sequencing has accelerated the identification of MCDs causing genes: in some cases, functional studies are needed to clarify the role of genetic variants. The aim of this PhD project has been to apply a multidisciplinary approach to identify causative mutations in patients with MCDs, validate the pathogenic role of the identified mutations, and assess the effectiveness of novel in vitro treatment for mTOR pathway related MCDs. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medical genetics  |2 bicssc 
653 |a MCDs 
653 |a Epilepsy 
653 |a NGS 
653 |a fibroblasts 
653 |a metformin 
856 4 0 |a www.oapen.org  |u https://library.oapen.org/bitstream/20.500.12657/55696/1/9788855183444.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/82317  |7 0  |z DOAB: description of the publication